Dr. Dorff on Role of Chemotherapy in mCRPC

preview_player
Показать описание
Tanya Dorff, MD, assistant professor of Clinical Medicine, Keck Medicine of University of Southern California, discusses the role of chemotherapy in patients with metastatic castration-resistant prostate cancer (mCRPC) and pivotal clinical trials that have explored this.
Рекомендации по теме
join shbcf.ru